New client programme to be supported from OXB’s FDA-approved, commercial scale viral vector manufacturing facility in Durham, North Carolina, ...
Oxford, UK – 2 June 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, will today host a Capital Markets Event for equity research analysts and institutional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results